Tsutomu Anraku
Niigata, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Late-Onset Bone Metastasis 46 Years After Initial Surgery for Pheochromocytoma: A Case Report.
Journal: IJU case reports
Published: May 15, 2025
A Case of ABO-Incompatible Kidney Transplantation for a False-Positive T and B-Cell Crossmatch Test Due to Anti-A Antibodies.
Journal: Transplantation proceedings
Published: November 12, 2024
Selective HDAC6 Inhibition Has the Potential for Anti-Cancer Effect in Renal Cell Carcinoma.
Journal: Journal of personalized medicine
Published: May 12, 2024
Targeting Pro-Survival Autophagy Enhanced GSK-3β Inhibition-Induced Apoptosis and Retarded Proliferation in Bladder Cancer Cells.
Journal: Current oncology (Toronto, Ont.)
Published: April 29, 2023
Successful treatment of immune-related cystitis with bladder hydrodistension.
Journal: IJU case reports
Published: January 19, 2023
Sarcomatoid urothelial carcinoma of the renal pelvis treated with immunotherapy.
Journal: BMC urology
Published: May 31, 2022
A 40-year-old man with a rapidly growing intrascrotal tumor in the fibroma-thecoma group.
Journal: IJU case reports
Published: January 04, 2022
Development of patient‑derived tumor organoids and a drug testing model for renal cell carcinoma.
Journal: Oncology reports
Published: April 01, 2021
Clinically relevant GSK‑3β inhibitor 9‑ING‑41 is active as a single agent and in combination with other antitumor therapies in human renal cancer.
Journal: International journal of molecular medicine
Published: July 08, 2019
Last Updated: 09/26/2026